| New Features for Child Metrics: Further Growth References and Blood Pressure Calculations | KORCAN DEMİR,Ergun KONAKÇI,GÜVEN ÖZKAYA,Belde DEMİR,Samim ÖZEN,Murat AYDIN,Feyza DARENDELİLER | 125–129 |
| A Proposal for the Interpretation of Serum IGF-I Concentration as Part of Laboratory Screening in Children with Growth Failure | Jan Maarten WIT,Martin BIDLINGMAIER,Christiaan De BRUIN,Wilma OOSTDIJK | 130–139 |
| A Proposal to Develop New References for Serum IGF-I Levels in Children | Michael B. RANKE | 140–142 |
| Evaluation of Thyroid Function Tests in Children with Chronic Liver Diseases | Şeyma Şebnem ÖN,Sezer ACAR,KORCAN DEMİR,AYHAN ABACI,Yeşim ÖZTÜRK,Sinem KAHVECİ ÇELİK,Ece BÖBER | 143–149 |
| Nationwide Turkish Cohort Study of Hypophosphatemic Rickets | Zeynep ŞIKLAR,Serap TURAN,Abdullah BEREKET,Tülay GÜRAN,Azad AKBARZADE,Firdevs BAŞ,AYHAN ABACI,KORCAN DEMİR,Ece BÖBER,Mehmet Nuri ÖZBEK,Cengiz KARA,Şükran POYRAZOĞLU,Murat AYDIN,Aslı Derya KARDELEN,Ömer TARIM,Erdal EREN,Nihal HATİPOĞLU,Muammer BÜYÜKİNAN,Nesibe AKYÜREK,Semra ÇETİNKAYA,Elvan BAYRAMOĞLU | 150–159 |
| Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis | William H. HOFFMAN,Takaki ISHIKAWA,James BLUM,Naoto TANI,Tomoya IKEDA,Carol M. ARTLETT | 160–167 |
| The Effect of Pubertal Stage on the Concentrations of the Novel Adipomyokine, Irisin, in Male Adolescents | Demet TAŞ,Alkım AKMAN ÖDEN,Ziya Erokay METİN,Sinem AKGÜL,Nuray KANBUR,Aslı PINAR | 168–174 |
| The Incidence and Demographic Distribution of Type 1 Diabetes Mellitus in Children Aged 16 or Younger Between 2000 and 2016 in Cyprus | Umut MOUSA,Hasan SAV,Osman KÖSEOĞULLARI,Ayşe DOĞAN,Neşe AKCAN,Rüveyde BUNDAK,Serap SOYTAÇ İNANÇLI | 175–179 |
| Association of Total and High Molecular Weight Adiponectin with Components of Metabolic Syndrome in Mexican Children | Javier A. MAGANA GOMEZ,Daniela MORENO-MASCARENO,Carla E. ANGULO ROJO,Gisela Duarte De La PENA | 180–188 |
| The Effects of Prehospital Care on Outcome in Pediatric Diabetic Ketoacidosis | Caner TURAN,Ali YURTSEVEN,Elif Gökçe BASA,Eylem ULAŞ SAZ | 189–196 |
| Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease | Kotb Abbass METWALLEY,Hekma Saad FARGHALY,Duaa MOHAMED RAFAAT,Asmaa MOHAMED ISMAIL,Ghada MOHAMED SAIED | 197–201 |
| Catecholamine-induced Myocarditis in a Child with Pheochromocytoma | Seyit Ahmet UÇAKTÜRK,Eda MENGEN,Emine AZAK,İbrahim İlker ÇETİN,Pınar KOCAAY,EMRAH ŞENEL | 202–205 |
| A Rare Etiology of 46,XY Disorder of Sex Development and Adrenal Insufficiency: A Case of MIRAGE Syndrome Caused by Mutations in the SAMD9 Gene | Eda MENGEN,Seyit Ahmet UÇAKTÜRK,Aynur KÜÇÜKÇONGAR YAVAŞ | 206–211 |
| A Novel Missense Mutation in Human Receptor Roundabout-1 (ROBO1) Gene Associated with Pituitary Stalk Interruption Syndrome | Ziqin LIU,Xiaobo CHEN | 212–217 |
| Hypoprolactinemia as a Clue to Diagnosis of Mild Central Hypothyroidism due to IGSF1 Deficiency | Anastasios PAPADIMITRIOU,Anna PAPADOPOULOU,Kleanthis KLEANTHOUS,Dimitrios PAPADIMITRIOU,Vassiliki PAPAEVANGELOU | 218–222 |
| Novel MTTP Gene Mutation in a Case of Abetalipoproteinemia with Central Hypothyroidism | Sezer ACAR | 223–224 |